Neural mechanisms of psychedelic visual imagery
Devon Stoliker, Katrin H. Preller, Leonardo Novelli, Alan Anticevic, Gary F. Egan, Franz X. Vollenweider, Adeel Razi
medRxiv September 9, 2022 preprint DOI: 10.1101/2022.09.07.22279700 via OpenAlex
Summary
AI-generated from the abstractA double-blind, placebo-controlled study of 24 healthy adults found that psilocybin, the active compound in magic mushrooms, alters visual brain connectivity in ways consistent with preclinical models. Under psilocybin, early visual and higher visual-association regions showed increased self-inhibition, while top-down feedback from association areas to earlier visual regions was enhanced. These connectivity changes were linked to decreased sensitivity to neural inputs and the perception of eyes-closed visual imagery. The findings suggest that psilocybin-induced visual imagery arises from reduced bottom-up gain and strengthened top-down influences, informing basic and clinical understanding of visual perception.
Study at a glance
| Characteristics | Double-blind, randomised, placebo-controlled, cross-over study Randomized |
|---|---|
| Sample size | 24 |
| Population | Healthy adults |
| Intervention | Psilocybin |
| Dose | 0.2mg/kg |
| Topics | Psilocybin |
| Keywords | Neuroscience Visual perception Hallucinogen Visual cortex |
| Citations | 5 |
| Key finding | Psilocybin increases self-inhibition in visual regions and enhances top-down connectivity from visual-association to early visual areas, which is associated with eyes-closed visual imagery. |
Abstract
Abstract Visual alterations under classic psychedelics can include rich phenomenological accounts of eyes-closed imagery. Preclinical evidence suggests agonism of the 5-HT2A receptor may reduce synaptic gain to produce psychedelic-induced imagery. However, this has not been investigated in humans. To infer the directed connectivity changes to visual sensory connectivity underlying psychedelic visual imagery in healthy adults, a double-blind, randomised, placebo-controlled, cross-over study was performed, and dynamic causal modelling was applied to the resting state eyes-closed functional MRI scans of 24 subjects after administration of 0.2mg/kg of the serotonergic psychedelic drug, psilocybin (magic mushrooms), or placebo. The effective connectivity model included the early visual area, fusiform gyrus, intraparietal sulcus, and inferior frontal gyrus. We observed a pattern of increased self-inhibition of both early visual and higher visual-association regions under psilocybin that was consistent with preclinical findings. We also observed a pattern of reduced inhibition from visual-association regions to earlier visual areas that indicated top-down connectivity is enhanced during visual imagery. The results were associated with behavioural measures taken immediately after the scans, suggesting psilocybin-induced decreased sensitivity to neural inputs is associated with the perception of eyes-closed visual imagery. The findings inform our basic and clinical understanding of visual perception. They reveal neural mechanisms that, by affecting balance, may increase the impact of top-down feedback connectivity on perception, which could contribute to the visual imagery seen with eyes-closed during psychedelic experiences.